teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 29 Projects Releases Packages Wiki Activity Actions 125

auto-fix: strip 1 broken wiki links
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details

Browse source 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
This commit is contained in:
Teleo Agents 2026-05-08 04:14:59 +00:00
parent 92f2f6e987
commit 09ce8bb479
1 changed files with 1 additions and 1 deletions
Show stats Download patch file Download diff file Expand all files Collapse all files

2
inbox/queue/2026-05-08-glp1-cocaine-use-disorder-phase2-recruiting-2025.md
View file

@ -66,6 +66,6 @@ intake_tier: research-task
**Context:** Cocaine use disorder is the highest-unmet-need SUD category. Two Phase 2 trials recruiting as of early 2025. No completed results. This archive serves as a tracking record for the extractor to know: don't extract efficacy claims yet, revisit when trial results publish.
## Curator Notes (structured handoff for extractor)
PRIMARY CONNECTION: [[GLP-1 receptor agonists reduce substance use disorder risk by 40-75%]] (if this claim exists or is proposed from Session 39 sources)
PRIMARY CONNECTION: GLP-1 receptor agonists reduce substance use disorder risk by 40-75% (if this claim exists or is proposed from Session 39 sources)
WHY ARCHIVED: Tracking the CUD trial status so future Vida sessions know exactly where the evidence stands — no completed RCT, two Phase 2 recruiting, check back 2027.
EXTRACTION HINT: Do NOT extract efficacy claims. Extract only: (1) the status fact that no pharmacotherapy exists for CUD and (2) the trial pipeline status. The All of Us OR=0.25 should be cited as the observational basis, with confidence flagged as experimental pending RCT.